Past Major Depression and Smoking Cessation Outcome: a Systematic Review and Meta-analysis Update

Overview

Journal Addiction

Specialty Psychiatry

Date 2012 Oct 18

PMID 23072580

Citations 81

Authors

Brian Hitsman

George D Papandonatos

Dennis E McChargue

Andrew DeMott

Maria Jose Herrera

Bonnie Spring

Belinda Borrelli

Raymond Niaura

Affiliations

Soon will be listed here.

Abstract

Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome.

Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association.

Results: MD+ smokers had 17% lower odds of short-term abstinence (n = 35, OR = 0.83, 95% CI = 0.72-0.95, P = 0.009) and 19% lower odds of long-term abstinence (n = 38, OR = 0.81, 95% CI = 0.67-0.97, P = 0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors.

Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.

Citing Articles

Interventions for tobacco use cessation in people living with HIV.

Mdege N, Shah S, Dogar O, Pool E, Weatherburn P, Siddiqi K Cochrane Database Syst Rev. 2024; 8:CD011120.

PMID: 39101506 PMC: 11299227. DOI: 10.1002/14651858.CD011120.pub3.

A smoking cessation intervention for rural veterans tailored to individual risk factors: A multicenter randomized clinical trial.

Vander Weg M, Howren M, Grant K, Prochazka A, Duffy S, Burke R J Subst Use Addict Treat. 2023; 156:209191.

PMID: 37866436 PMC: 11700485. DOI: 10.1016/j.josat.2023.209191.

Texas tobacco quitline knowledge, attitudes, and practices within healthcare agencies serving individuals with behavioral health needs: A multimethod study.

Britton M, Rogova A, Chen T, Martinez Leal I, Kyburz B, Williams T Prev Med Rep. 2023; 35:102256.

PMID: 37752980 PMC: 10518765. DOI: 10.1016/j.pmedr.2023.102256.

Smoking Cessation and Changes in Anxiety and Depression in Adults With and Without Psychiatric Disorders.

Wu A, Gao M, Aveyard P, Taylor G JAMA Netw Open. 2023; 6(5):e2316111.

PMID: 37256615 PMC: 10233414. DOI: 10.1001/jamanetworkopen.2023.16111.

Change in cardiovascular health among adults with current or past major depressive disorder enrolled in intensive smoking cessation treatment.

Carroll A, Huffman M, Wileyto E, Khan S, Fox E, Smith J J Affect Disord. 2023; 333:527-534.

PMID: 37119868 PMC: 10236931. DOI: 10.1016/j.jad.2023.04.089.

References

Swan G, Jack L, Curry S, Chorost M, Javitz H, McAfee T . Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine Tob Res. 2003; 5(6):911-21. DOI: 10.1080/14622200310001646903. View

van der Meer R, Willemsen M, Smit F, Cuijpers P, Schippers G . Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial. Addiction. 2010; 105(11):1991-9. DOI: 10.1111/j.1360-0443.2010.03057.x. View

Hall S, Munoz R, Reus V . Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994; 62(1):141-6. DOI: 10.1037//0022-006x.62.1.141. View

Hall S, Munoz R, Reus V, Sees K, Duncan C, Humfleet G . Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol. 1996; 64(5):1003-9. DOI: 10.1037//0022-006x.64.5.1003. View

Munoz R, Barrera A, Delucchi K, Penilla C, Torres L, Perez-Stable E . International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine Tob Res. 2009; 11(9):1025-34. PMC: 2725004. DOI: 10.1093/ntr/ntp090. View

Parsons A, Ingram J, Inglis J, Aveyard P, Johnstone E, Brown K . A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation. Drug Alcohol Depend. 2009; 102(1-3):116-22. DOI: 10.1016/j.drugalcdep.2009.02.006. View

Hayford K, Patten C, Rummans T, Schroeder D, Offord K, Croghan I . Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry. 1999; 174:173-8. DOI: 10.1192/bjp.174.2.173. View

McChargue D, Cook J . Depression vulnerability within smoking research: How accurate are one-item screening items?. Addict Behav. 2006; 32(2):404-9. DOI: 10.1016/j.addbeh.2006.05.006. View

Niaura R, Britt D, Borrelli B, Shadel W, Abrams D, Goldstein M . History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 2000; 1(3):251-7. DOI: 10.1080/14622299050011371. View

10.

Munoz R, Lenert L, Delucchi K, Stoddard J, Perez J, Penilla C . Toward evidence-based Internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine Tob Res. 2006; 8(1):77-87. DOI: 10.1080/14622200500431940. View

11.

Oncken C, Cooney J, Feinn R, Lando H, Kranzler H . Transdermal nicotine for smoking cessation in postmenopausal women. Addict Behav. 2006; 32(2):296-309. DOI: 10.1016/j.addbeh.2006.04.004. View

12.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

13.

Takkouche B, Cadarso-Suarez C, Spiegelman D . Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol. 1999; 150(2):206-15. DOI: 10.1093/oxfordjournals.aje.a009981. View

14.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

15.

Hall S, Humfleet G, Reus V, Munoz R, Cullen J . Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry. 2004; 161(11):2100-7. DOI: 10.1176/appi.ajp.161.11.2100. View

16.

Smith S, Jorenby D, Leischow S, Nides M, Rennard S, Johnston J . Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res. 2003; 5(1):99-109. DOI: 10.1080/1462220021000060437. View

17.

Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M . Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. BMJ. 2008; 336(7655):1223-7. PMC: 2405820. DOI: 10.1136/bmj.39545.852616.BE. View

18.

Hall S, Humfleet G, Munoz R, Reus V, Robbins J, Prochaska J . Extended treatment of older cigarette smokers. Addiction. 2009; 104(6):1043-52. PMC: 2718733. DOI: 10.1111/j.1360-0443.2009.02548.x. View

19.

van der Meer R, Willemsen M, Smit F, Cuijpers P . Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013; (8):CD006102. DOI: 10.1002/14651858.CD006102.pub2. View

20.

Keuthen N, Niaura R, Borrelli B, Goldstein M, DePue J, Murphy C . Comorbidity, smoking behavior and treatment outcome. Psychother Psychosom. 2000; 69(5):244-50. DOI: 10.1159/000012403. View